MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -7.5% | 79 | 0.0% | 0.00% | – |
| Q4 2022 | $40 | -99.9% | 79 | +216.0% | 0.00% | – |
| Q4 2020 | $34,000 | +78.9% | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $19,000 | +26.7% | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -73.7% | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $57,000 | +235.3% | 25 | -7.4% | 0.00% | – |
| Q3 2019 | $17,000 | -26.1% | 27 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | -14.8% | 27 | +8.0% | 0.00% | – |
| Q1 2019 | $27,000 | -99.1% | 25 | -99.5% | 0.00% | – |
| Q4 2018 | $2,851,000 | -35.3% | 4,792 | 0.0% | 0.00% | – |
| Q3 2018 | $4,409,000 | +112.1% | 4,792 | 0.0% | 0.00% | – |
| Q2 2018 | $2,079,000 | -86.5% | 4,792 | -76.2% | 0.00% | – |
| Q1 2018 | $15,393,000 | -20.2% | 20,127 | +21.1% | 0.00% | – |
| Q4 2017 | $19,282,000 | +183.6% | 16,622 | +222.7% | 0.00% | – |
| Q3 2017 | $6,799,000 | -27.3% | 5,151 | -6.9% | 0.00% | – |
| Q2 2017 | $9,351,000 | – | 5,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COURAGE CAPITAL MANAGEMENT LLC | 1,700,000 | $2,210,000 | 1.18% |
| Sargent Investment Group, LLC | 3,245,021 | $4,219,000 | 1.02% |
| Arkadios Wealth Advisors | 1,399,000 | $1,818,000 | 0.26% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $1,004,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 744,024 | $967,000 | 0.10% |
| Platform Technology Partners | 165,160 | $215,000 | 0.10% |
| DCF Advisers, LLC | 154,500 | $201,000 | 0.09% |
| Main Street Financial Solutions, LLC | 400,826 | $521,000 | 0.08% |
| Investors Financial Group, LLC | 80,000 | $104,000 | 0.06% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $780,000 | 0.04% |